
EquityIndex FundsVery High Risk
Direct
NAV (16-Oct-26)
Returns (Since Inception)
Fund Size
₹7,962 Cr
Expense Ratio
1.00%
ISIN
INF789F1AUT5
Minimum SIP
₹1,000
Exit Load
No Charges
Inception Date
10 Mar 2021
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
-8.12%
— (Cat Avg.)
3 Years
+8.22%
— (Cat Avg.)
5 Years
+6.62%
— (Cat Avg.)
Since Inception
+13.38%
— (Cat Avg.)
| Equity | ₹7,956.11 Cr | 99.93% |
| Others | ₹5.56 Cr | 0.07% |
All Holdings
Equity
Debt & Others
| Name | Type | Amount | Holdings |
|---|---|---|---|
| Laurus Labs Ltd | Equity | ₹520.66 Cr | 6.54% |
| Multi Commodity Exchange of India Ltd | Equity | ₹481.06 Cr | 6.04% |
| Tata Steel Ltd | Equity | ₹401.28 Cr | 5.04% |
| Shriram Finance Ltd | Equity | ₹399.29 Cr | 5.02% |
| Hindalco Industries Ltd | Equity | ₹399.28 Cr | 5.02% |
| NTPC Ltd | Equity | ₹374.26 Cr | 4.70% |
| Adani Power Ltd | Equity | ₹367.62 Cr | 4.62% |
| Cummins India Ltd | Equity | ₹354.75 Cr | 4.46% |
| GE Vernova T&D India Ltd | Equity | ₹344.26 Cr | 4.32% |
| Vedanta Ltd | Equity | ₹338.76 Cr | 4.25% |
| BSE Ltd | Equity | ₹329.39 Cr | 4.14% |
| The Federal Bank Ltd | Equity | ₹298.06 Cr | 3.74% |
| Bharat Heavy Electricals Ltd | Equity | ₹289.91 Cr | 3.64% |
| Samvardhana Motherson International Ltd | Equity | ₹266.02 Cr | 3.34% |
| Bharat Forge Ltd | Equity | ₹254.35 Cr | 3.19% |
| CG Power & Industrial Solutions Ltd | Equity | ₹241.62 Cr | 3.03% |
| Hitachi Energy India Ltd Ordinary Shares | Equity | ₹230.95 Cr | 2.90% |
| Torrent Pharmaceuticals Ltd | Equity | ₹226.62 Cr | 2.85% |
| Adani Energy Solutions Ltd | Equity | ₹222.19 Cr | 2.79% |
| National Aluminium Co Ltd | Equity | ₹211.14 Cr | 2.65% |
| Polycab India Ltd | Equity | ₹197.23 Cr | 2.48% |
| Solar Industries India Ltd | Equity | ₹171.89 Cr | 2.16% |
| Adani Green Energy Ltd | Equity | ₹164.86 Cr | 2.07% |
| Vodafone Idea Ltd | Equity | ₹160.88 Cr | 2.02% |
| ABB India Ltd | Equity | ₹147.14 Cr | 1.85% |
| Glenmark Pharmaceuticals Ltd | Equity | ₹139.34 Cr | 1.75% |
| Steel Authority Of India Ltd | Equity | ₹133.88 Cr | 1.68% |
| KEI Industries Ltd | Equity | ₹112.71 Cr | 1.42% |
| Aditya Birla Capital Ltd | Equity | ₹106.72 Cr | 1.34% |
| L&T Finance Ltd | Equity | ₹69.98 Cr | 0.88% |
| Net Current Assets | Cash | ₹5.56 Cr | 0.07% |
Large Cap Stocks
66.37%
Mid Cap Stocks
33.56%
Small Cap Stocks
--
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Industrials | ₹2,172.92 Cr | 27.29% |
| Financial Services | ₹1,684.5 Cr | 21.16% |
| Basic Materials | ₹1,656.24 Cr | 20.80% |
| Utilities | ₹1,128.93 Cr | 14.18% |
| Healthcare | ₹886.62 Cr | 11.14% |
| Consumer Cyclical | ₹266.02 Cr | 3.34% |
| Communication Services | ₹160.88 Cr | 2.02% |
Standard Deviation
This fund
20.17%
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
0.22
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since March 2021
Since May 2022
Since June 2026
ISIN INF789F1AUT5 | Expense Ratio 1.00% | Exit Load No Charges | Fund Size ₹7,962 Cr | Age 5 years 7 months | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark Nifty200 Momentum 30 TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Total AUM
₹3,71,805 Cr
Address
UTI Towers, Gn Block, Mumbai, 400 051
Your principal amount will be at Very High Risk

Download Dezerv App
Track and monitor all
your investments